LENSAR, Inc. (LNSR)
USD 13.69
(-2.63%)
USD 13.69
(-2.63%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 69.58 Million USD | 24.61% |
| 2022 | 55.84 Million USD | -15.98% |
| 2021 | 66.46 Million USD | -15.99% |
| 2020 | 79.12 Million USD | 129.09% |
| 2019 | 34.53 Million USD | 19.56% |
| 2018 | 28.88 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 61.4 Million USD | -7.15% |
| 2024 Q1 | 66.13 Million USD | -4.96% |
| 2023 Q1 | 51.96 Million USD | -6.95% |
| 2023 FY | 69.58 Million USD | 24.61% |
| 2023 Q4 | 69.58 Million USD | -1.79% |
| 2023 Q3 | 70.85 Million USD | -0.48% |
| 2023 Q2 | 71.19 Million USD | 37.02% |
| 2022 Q3 | 54.8 Million USD | -6.64% |
| 2022 Q2 | 58.7 Million USD | -2.65% |
| 2022 Q1 | 60.29 Million USD | -9.28% |
| 2022 FY | 55.84 Million USD | -15.98% |
| 2022 Q4 | 55.84 Million USD | 1.9% |
| 2021 Q1 | 73.54 Million USD | -7.05% |
| 2021 FY | 66.46 Million USD | -15.99% |
| 2021 Q4 | 66.46 Million USD | -2.4% |
| 2021 Q3 | 68.1 Million USD | -6.05% |
| 2021 Q2 | 72.48 Million USD | -1.44% |
| 2020 Q4 | 79.12 Million USD | -1.97% |
| 2020 Q2 | 38.02 Million USD | 0.0% |
| 2020 Q3 | 80.71 Million USD | 112.28% |
| 2020 Q1 | - USD | -100.0% |
| 2020 FY | 79.12 Million USD | 129.09% |
| 2019 Q4 | 34.53 Million USD | 0.0% |
| 2019 FY | 34.53 Million USD | 19.56% |
| 2019 Q1 | - USD | 0.0% |
| 2018 FY | 28.88 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 31.36 Million USD | -121.848% |
| BrainsWay Ltd. | 62.97 Million USD | -10.501% |
| Cerus Corporation | 197.74 Million USD | 64.811% |
| Envoy Medical, Inc. | 7.64 Million USD | -810.798% |
| electroCore, Inc. | 16.38 Million USD | -324.635% |
| Helius Medical Technologies, Inc. | 7.69 Million USD | -804.641% |
| IceCure Medical Ltd | 16.41 Million USD | -324.04% |
| Inogen, Inc. | 326.19 Million USD | 78.668% |
| OrthoPediatrics Corp. | 449.58 Million USD | 84.522% |
| Lucid Diagnostics Inc. | 27.27 Million USD | -155.171% |
| Monogram Orthopaedics, Inc. | 16.57 Million USD | -319.717% |
| MaxCyte, Inc. | 268.27 Million USD | 74.062% |
| NeuroOne Medical Technologies Corporation | 8.09 Million USD | -759.359% |
| Nexalin Technology, Inc. | 3.63 Million USD | -1815.931% |
| Orthofix Medical Inc. | 925.31 Million USD | 92.48% |
| PAVmed Inc | 33.11 Million USD | -110.106% |
| Rapid Micro Biosystems, Inc. | 143.45 Million USD | 51.492% |
| RxSight, Inc. | 182.55 Million USD | 61.882% |
| Sight Sciences, Inc. | 166.65 Million USD | 58.245% |
| SI-BONE, Inc. | 230.42 Million USD | 69.801% |
| TELA Bio, Inc. | 78.04 Million USD | 10.843% |
| Treace Medical Concepts, Inc. | 251.9 Million USD | 72.377% |
| Vivos Therapeutics, Inc. | 10.73 Million USD | -548.509% |
| Acutus Medical, Inc. | 53.96 Million USD | -28.957% |
| Talis Biomedical Corporation | 98.34 Million USD | 29.24% |
| Spectral AI, Inc. | 10.69 Million USD | -550.814% |
| Nano-X Imaging Ltd. | 218.64 Million USD | 68.175% |
| CVRx, Inc. | 115.22 Million USD | 39.612% |
| DIH Holding US, Inc. Warrants | 58.66 Million USD | -18.622% |
| PetVivo Holdings, Inc. | 3.11 Million USD | -2133.687% |
| Bioventus Inc. | 810.91 Million USD | 91.419% |
| Venus Concept Inc. | 93.65 Million USD | 25.7% |
| TriSalus Life Sciences, Inc. | 25.72 Million USD | -170.496% |
| LivaNova PLC | 2.42 Billion USD | 97.136% |
| 908 Devices Inc. | 202.98 Million USD | 65.718% |
| Alphatec Holdings, Inc. | 805.2 Million USD | 91.358% |
| Nemaura Medical Inc. | 14.56 Million USD | -377.813% |
| NeuroPace, Inc. | 107.65 Million USD | 35.361% |
| Apyx Medical Corporation | 79.24 Million USD | 12.185% |
| Cutera, Inc. | 346.29 Million USD | 79.906% |
| STRATA Skin Sciences, Inc. | 42.01 Million USD | -65.615% |
| BioSig Technologies, Inc. | 1.79 Million USD | -3770.133% |
| Anika Therapeutics, Inc. | 270.63 Million USD | 74.288% |
| ClearPoint Neuro, Inc. | 42.66 Million USD | -63.112% |
| Integra LifeSciences Holdings Corporation | 3.78 Billion USD | 98.16% |
| Axonics, Inc. | 719.92 Million USD | 90.334% |
| Outset Medical, Inc. | 313.8 Million USD | 77.825% |
| IRIDEX Corporation | 34.43 Million USD | -102.071% |
| PROCEPT BioRobotics Corporation | 404.71 Million USD | 82.807% |
| IRadimed Corporation | 92.15 Million USD | 24.492% |
| Tivic Health Systems, Inc. | 5.25 Million USD | -1224.419% |
| INVO Bioscience, Inc. | 20.88 Million USD | -233.137% |
| Telesis Bio, Inc. | 70.41 Million USD | 1.173% |
| Viemed Healthcare, Inc. | 154.1 Million USD | 54.845% |
| Varex Imaging Corporation | 1.24 Billion USD | 94.431% |
| Quipt Home Medical Corp. | 247.4 Million USD | 71.874% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -647.422% |
| Pulmonx Corporation | 178.95 Million USD | 61.115% |
| Dynatronics Corporation | 25.94 Million USD | -168.248% |
| Modular Medical, Inc. | 13.8 Million USD | -403.983% |
| ReShape Lifesciences Inc. | 10.72 Million USD | -548.69% |
| Semler Scientific, Inc. | 78.06 Million USD | 10.863% |
| InMode Ltd. | 863.28 Million USD | 91.94% |
| Bruker Corporation | 4.24 Billion USD | 98.363% |
| Cytosorbents Corporation | 53.26 Million USD | -30.65% |
| DexCom, Inc. | 6.26 Billion USD | 98.889% |
| Align Technology, Inc. | 6.08 Billion USD | 98.856% |
| Viveve Medical, Inc. | 25.91 Million USD | -168.533% |
| ZimVie Inc. | 1.2 Billion USD | 94.227% |
| Movano Inc. | 9.42 Million USD | -638.616% |
| Cytek Biosciences, Inc. | 497.66 Million USD | 86.018% |
| Nexalin Technology, Inc. | 3.63 Million USD | -1815.931% |
| DIH Holdings US, Inc. Class A Common Stock | 58.66 Million USD | -18.622% |
| Tandem Diabetes Care, Inc. | 952.65 Million USD | 92.696% |
| Profound Medical Corp. | 43.68 Million USD | -59.283% |
| Insulet Corporation | 2.58 Billion USD | 97.311% |
| enVVeno Medical Corporation | 48.63 Million USD | -43.076% |
| Surmodics, Inc. | 185.73 Million USD | 62.535% |
| iCAD, Inc. | 41.41 Million USD | -68.007% |
| Nuwellis, Inc. | 9.77 Million USD | -612.231% |
| Biotricity, Inc. | 5.94 Million USD | -1070.947% |
| iRhythm Technologies, Inc. | 433.14 Million USD | 83.935% |
| Aethlon Medical, Inc. | 8.24 Million USD | -743.866% |
| InspireMD, Inc. | 47.64 Million USD | -46.055% |
| PAVmed Inc. | 33.11 Million USD | -110.106% |
| BIOLASE, Inc. | 35.1 Million USD | -98.242% |
| Beyond Air, Inc. | 56.96 Million USD | -22.163% |
| FONAR Corporation | 214.24 Million USD | 67.521% |
| AxoGen, Inc. | 196.82 Million USD | 64.647% |
| Vivani Medical, Inc. | 45.79 Million USD | -51.942% |
| Tactile Systems Technology, Inc. | 281.43 Million USD | 75.275% |
| Inari Medical, Inc. | 674.23 Million USD | 89.679% |
| UFP Technologies, Inc. | 404.13 Million USD | 82.782% |
| QT Imaging Holdings, Inc. | 23.39 Million USD | -197.39% |
| Heart Test Laboratories, Inc. | 9.5 Million USD | -632.234% |
| Tenon Medical, Inc. | 6.34 Million USD | -996.69% |
| Autonomix Medical, Inc. Common Stock | 9.4 Million USD | -639.715% |
| Co-Diagnostics, Inc. | 103.64 Million USD | 32.864% |
| AdaptHealth Corp. | 4.61 Billion USD | 98.494% |
| Sintx Technologies, Inc. | 15.36 Million USD | -352.88% |
| NanoVibronix, Inc. | 6.67 Million USD | -942.628% |
| Quanterix Corporation | 425.01 Million USD | 83.627% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -647.422% |
| Sensus Healthcare, Inc. | 53.72 Million USD | -29.516% |
| Pacific Biosciences of California, Inc. | 1.74 Billion USD | 96.015% |
| TransMedics Group, Inc. | 706.04 Million USD | 90.144% |
| ReWalk Robotics Ltd. | 63.19 Million USD | -10.117% |
| NeuroMetrix, Inc. | 21.42 Million USD | -224.793% |
| Hyperfine, Inc. | 94.19 Million USD | 26.13% |
| Establishment Labs Holdings Inc. | 268.64 Million USD | 74.097% |
| Biomerica, Inc. | 9.25 Million USD | -651.945% |
| Bone Biologics Corporation | 3.73 Million USD | -1761.675% |
| AVITA Medical, Inc. | 144.33 Million USD | 51.791% |
| Bluejay Diagnostics, Inc. | 4.86 Million USD | -1329.281% |
| Silk Road Medical, Inc | 265.3 Million USD | 73.772% |